Biogen (BIIB) option implied volatility increases after Korea Economic Daily report of buyout talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Samsung BioLogics Said Biogen (BIIB) Buyout Rumor 'Untrue'
December 29, 2021 11:59 PM ESTSamsung BioLogics said a report that Samsung Group was in talks to acquire Biogen Inc. (NASDAQ: BIIB) is not true.
... MoreBiogen (BIIB) Could be Valued at $42B Cash in Samsung Deal, Here Are Key Questions According to Truist Securities
December 29, 2021 5:01 PM ESTTruist analyst Robyn Karnauskas reiterates a "Buy" rating and $502 price target on shares of Biogen (NASDAQ: BIIB), following rumors of potential takeover of the company by Samsung Group.
The analyst quotes:
"While there is no price set yet, Biogen approached Samsung to... More